Virpax Pharmaceuticals, Inc.Virpax Pharmaceuticals, Inc.Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals, Inc.

No trades
See on Supercharts

Analyst rating

Based on 1 analyst giving stock ratings to VRPX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


VRPX EPS for the last quarter is −1.75 USD despite the estimation of −1.53 USD. In the next quarter EPS is expected to reach −0.54 USD. Track more of Virpax Pharmaceuticals, Inc. financials and stay on top of what is up with the company.